Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study
- PMID: 29387573
- PMCID: PMC5787996
Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study
Abstract
Objectives: A correlation between hyperhomocysteinemia, and depression has been reported. Saffron (Crocus sativus) is recommended for treatment of depression; hence, in this study the effect of co-administration of saffron and fluoxetine on plasma homocysteine and depression was evaluated.
Material and methods: This was a 4-week randomized and double-blind clinical trial which was conducted from March 2013 to February 2014. In this trial, 40 male and females (20-55 years old) diagnosed with severe depression were selected and following filing the Beck form, were randomly divided into two groups. Experimental group was treated with fluoxetine 20 mg/day and saffron 30 mg /day and the control group received placebo and fluoxetine 20 mg/day for four weeks. Before treatment and at the end of the study, fasting blood samples were collected. For females, blood samples were collected on the third day of their menstrual cycle.
Results: A significant reduction of homocysteine levels was observed in both sex in the experimental group compared to before treatment (p<0.04), while no such significant change was observed in the control group. A Beck questionnaire value showed lower level in both groups on the last day of treatment as compared to before treatment. There was no significant difference between the two groups in Beck value neither before nor after treatment.
Conclusion: Saffron has beneficial effects on depression and homocysteine level in patients with major depression.
Keywords: Crocus Sativus; Homocysteine; Major Depression; Saffron.
Figures






Similar articles
-
A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression.J Clin Pharm Ther. 2020 Feb;45(1):134-143. doi: 10.1111/jcpt.13040. Epub 2019 Oct 10. J Clin Pharm Ther. 2020. PMID: 31602695 Clinical Trial.
-
Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.J Ethnopharmacol. 2005 Feb 28;97(2):281-4. doi: 10.1016/j.jep.2004.11.004. Epub 2005 Jan 6. J Ethnopharmacol. 2005. PMID: 15707766 Clinical Trial.
-
Study the effects of saffron on depression and lipid profiles: A double blind comparative study.Asian J Psychiatr. 2016 Aug;22:174-6. doi: 10.1016/j.ajp.2015.10.012. Epub 2015 Nov 10. Asian J Psychiatr. 2016. PMID: 26611571 Clinical Trial.
-
Safety and Efficacy of Saffron (Crocus sativus L.) for Treating Mild to Moderate Depression: A Systematic Review and Meta-analysis.J Nerv Ment Dis. 2020 Apr;208(4):269-276. doi: 10.1097/NMD.0000000000001118. J Nerv Ment Dis. 2020. PMID: 32221179
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
Cited by
-
Antianhedonic and Antidepressant Effects of Affron®, a Standardized Saffron (Crocus Sativus L.) Extract.Molecules. 2020 Jul 15;25(14):3207. doi: 10.3390/molecules25143207. Molecules. 2020. PMID: 32679643 Free PMC article.
-
The effect of saffron (Crocus sativus L.) supplementation on blood pressure, and renal and liver function in patients with type 2 diabetes mellitus: A double-blinded, randomized clinical trial.Avicenna J Phytomed. 2019 Jul-Aug;9(4):322-333. Avicenna J Phytomed. 2019. PMID: 31309071 Free PMC article.
-
Betaine Ameliorates Depressive-Like Behaviors in Zinc Oxide Nanoparticles Exposed Mice.Biol Trace Elem Res. 2022 Nov;200(11):4771-4781. doi: 10.1007/s12011-021-03068-4. Epub 2022 Jan 6. Biol Trace Elem Res. 2022. PMID: 34993911
-
Ethnomedicinal uses of plants for the treatment of nervous disorders at the herbal markets of Bojnord, North Khorasan Province, Iran.Avicenna J Phytomed. 2019 Mar-Apr;9(2):153-163. Avicenna J Phytomed. 2019. PMID: 30984580 Free PMC article.
-
Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus L.Pharmaceuticals (Basel). 2022 Dec 30;16(1):58. doi: 10.3390/ph16010058. Pharmaceuticals (Basel). 2022. PMID: 36678554 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources